Positive Patient Stories™

Paratek R&D Day Summary and Slides


Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, hosted an R&D Day on Thursday, November 17, 2016, from 1:00 p.m. to 3:00 p.m. ET at Lotte Palace Hotel in New York City.

During the R&D day, Paratek’s management team and opinion leaders in the field of antibiotics development and infectious disease discussed progress of the clinical development program for omadacycline, including the following:

  • Provided a company update
  • Discussed the company’s efforts to advance clinical development for omadacycline’s use in UTI
  • Reported results from additional registration enabling Phase 1 studies
  • Clinical unmet needs in ABSSSI, CABP and UTI and the value of an IV and Oral treatment option

Speakers included:

Keith Rodvold, Pharm D
University of Illinois at Chicago
Chicago, IL

J. Scott Overcash, MD
Grossmont Emergency Medical Group
San Diego, CA

Tom Lodise, Pharm D, PhD
Albany College of Pharmacy and Health Sciences
Albany, NY

Alpesh Amin, MD
University of California,
Irvine, CA


Slides presented at the R&D Day can be accessed here>>



12/14/2016 12:00:00 AM

Talk with the Paratek Team

Send us an inquiry by submitting a form directly on the site or give us a call.